Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$25.29 -1.14 (-4.31%)
At close: Oct 1, 2026 · 4:00 PM EDT

Arcutis Biotherapeutics (ARQT) Return on Equity [ROE] (2020 - 2026)

Updated

Arcutis Biotherapeutics (ARQT) posted Return on Equity [ROE] of 13.89% for Q2 2026, up 80.13 percentage points from -66.24% a year earlier and up 15.16 percentage points from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Arcutis Biotherapeutics' Return on Equity [ROE] came in at -9.32%, up 104.44 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of +123.61 percentage points (FY2020 to FY2025).
  • In prior years, Arcutis Biotherapeutics' Return on Equity [ROE] was -113.76% in FY2024 (+62.03 pp), -175.79% in FY2023 (-52.99 pp), -122.80% in FY2022 (-50.18 pp) and -72.62% in FY2021 (+60.31 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] in data going back to Q1 2020.
  • On a year-over-year basis, Return on Equity [ROE] has increased in each of the last ten quarters, with an average year-over-year change of +127.14 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2024, with a gain of 307.11 percentage points; the weakest was Q3 2023, with a drop of 287.55 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -1.27% (Q1 2026), -9.31% (Q4 2025) and -29.84% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Arcutis Biotherapeutics 3.32 Bn 2.60 Bn 118.92 Mn 13.89%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.89%
Mar 31, 2026 -1.27%
Dec 31, 2025 -9.31%
Sep 30, 2025 -29.84%
Jun 30, 2025 -66.24%
Mar 31, 2025 -86.42%
Dec 31, 2024 -89.15%
Sep 30, 2024 -113.99%
Jun 30, 2024 -96.63%
Mar 31, 2024 -138.66%
Dec 31, 2023 -387.25%
Sep 30, 2023 -421.10%
Jun 30, 2023 -300.42%
Mar 31, 2023 -187.60%
Dec 31, 2022 -129.91%
Sep 30, 2022 -133.56%
Jun 30, 2022 -116.07%
Mar 31, 2022 -85.20%
Dec 31, 2021 -62.52%
Sep 30, 2021 -43.55%
API Access

Arcutis Biotherapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARQT&period=max&api_key=YOUR_API_KEY